Compare the Effectiveness and Safety of Genoss® DCB and IN.PACT Admiral® DCB in Patients With Peripheral Artery Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 119 participants.

Also called NCT05134545

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 119 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05134545
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05134545. Randomized; double masking; primary purpose treatment. Start 2019-03-24 (actual); primary completion 2022-12-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Compare the Effectiveness and Safety of Genoss® DCB and IN.PACT Admiral® DCB in Patients With Peripheral Artery Disease
Condition
Peripheral Artery Disease
Condition
De Novo Stenosis
Intervention (Device)
Genoss® DCB
Intervention (Device)
IN.PACT Admiral® DCB
Lead sponsor
Genoss Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct05134545
Content hash
401a6e3f48a68103c6fb3678bea3d1d3c0ca20a5c0acfad2cda8077e28c600f4